Menu
GeneBe

12-21470225-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_002907.4(RECQL):c.1919G>A(p.Gly640Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G640R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 29)

Consequence

RECQL
NM_002907.4 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.872
Variant links:
Genes affected
RECQL (HGNC:9948): (RecQ like helicase) The protein encoded by this gene is a member of the RecQ DNA helicase family. DNA helicases are enzymes involved in various types of DNA repair, including mismatch repair, nucleotide excision repair and direct repair. The encoded protein is involved in the processing of Holliday junctions, the suppression of sister chromatid exchanges, telomere maintenance, and is required for genotoxic stress resistance. Defects in this gene have been associated with several types of cancer. [provided by RefSeq, Jan 2017]
PYROXD1 (HGNC:26162): (pyridine nucleotide-disulphide oxidoreductase domain 1) This gene encodes a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins that catalyze the pyridine nucleotide-dependent reduction of thiol residues in other proteins. The encoded protein belongs to the class I pyridine nucleotide-disulphide oxidoreductase family but lacks the C-terminal dimerization domain found in other family members and instead has a C-terminal nitrile reductase domain. It localizes to the nucleus and to striated sarcomeric compartments. Naturally occurring mutations in this gene cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. A pseudogene of this gene has been defined on chromosome 11. [provided by RefSeq, Apr 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.117063016).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RECQLNM_002907.4 linkuse as main transcriptc.1919G>A p.Gly640Glu missense_variant 15/15 ENST00000444129.7
PYROXD1NM_024854.5 linkuse as main transcriptc.*1471C>T 3_prime_UTR_variant 12/12 ENST00000240651.14

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RECQLENST00000444129.7 linkuse as main transcriptc.1919G>A p.Gly640Glu missense_variant 15/152 NM_002907.4 P1
RECQLENST00000421138.6 linkuse as main transcriptc.1919G>A p.Gly640Glu missense_variant 16/161 P1
PYROXD1ENST00000240651.14 linkuse as main transcriptc.*1471C>T 3_prime_UTR_variant 12/121 NM_024854.5 P1Q8WU10-1
PYROXD1ENST00000538582.5 linkuse as main transcriptc.*1471C>T 3_prime_UTR_variant 12/122 Q8WU10-2

Frequencies

GnomAD3 genomes
Cov.:
29
GnomAD4 exome
Cov.:
38
GnomAD4 genome
Cov.:
29

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 07, 2022The p.G640E variant (also known as c.1919G>A), located in coding exon 14 of the RECQL gene, results from a G to A substitution at nucleotide position 1919. The glycine at codon 640 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.067
T
BayesDel_noAF
Benign
-0.33
Cadd
Benign
15
Dann
Uncertain
0.99
DEOGEN2
Benign
0.15
T;T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.66
D
M_CAP
Benign
0.0073
T
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L;L
MutationTaster
Benign
1.0
D;D;N;N
PrimateAI
Benign
0.41
T
PROVEAN
Benign
0.47
N;N
REVEL
Benign
0.091
Sift
Benign
0.11
T;T
Sift4G
Benign
0.21
T;T
Polyphen
0.0080
B;B
Vest4
0.35
MutPred
0.19
Gain of solvent accessibility (P = 0.0281);Gain of solvent accessibility (P = 0.0281);
MVP
0.62
MPC
2.3
ClinPred
0.59
D
GERP RS
3.3
Varity_R
0.052
gMVP
0.030

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-21623159; API